CCMSX
Price
$14.44
Change
-$0.00 (-0.00%)
Updated
Oct 7 closing price
VSMAX
Price
$115.98
Change
-$0.14 (-0.12%)
Updated
Oct 17 closing price
Ad is loading...

CCMSX vs VSMAX

Header iconCCMSX vs VSMAX Comparison
Open Charts CCMSX vs VSMAXBanner chart's image
Cardinal Small Cap Value Institutional
Price$14.44
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Index Adm
Price$115.98
Change-$0.14 (-0.12%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CCMSX vs VSMAX Comparison Chart
Loading...
VS
CCMSX vs. VSMAX commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCMSX is a Buy and VSMAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VSMAX has more cash in the bank: 152B vs. CCMSX (24M). VSMAX pays higher dividends than CCMSX: VSMAX (1.42) vs CCMSX (1.11). CCMSX was incepted earlier than VSMAX: CCMSX (11 years) vs VSMAX (24 years). CCMSX is a more actively managed with annual turnover of: 29.00 vs. VSMAX (12.00). VSMAX has a lower initial minimum investment than CCMSX: VSMAX (3000) vs CCMSX (1000000). VSMAX annual gain was more profitable for investors over the last year : 28.45 vs. CCMSX (22.55). VSMAX return over 5 years is better than : 59.55 vs. CCMSX (27.50).
CCMSXVSMAXCCMSX / VSMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years24 years-
Gain YTD9.20813.90966%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets24M152B0%
Annual Yield % from dividends1.111.4278%
Returns for 1 year22.5528.4579%
Returns for 3 years-1.538.07-19%
Returns for 5 years27.5059.5546%
Returns for 10 years66.93137.9749%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TASCX22.380.39
+1.77%
Third Avenue Small Cap Value Instl
FADAX23.430.23
+0.99%
Fidelity Advisor Dividend Growth A
BPRRX14.720.07
+0.48%
Boston Partners Long/Short Rsrch Inv
JHUKX32.090.08
+0.25%
JPMorgan Emerging Markets Equity R4
EFCNX20.38N/A
N/A
Emerald Insights Investor